Prednison acis 20 mg clinical trials
3 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase 2, Randomized, Open-Label Study of Two Dose Levels of Vobramitamab Duocarmazine in Participants with Metastatic Castration-Resistant Prostate Cancer (TAMARACK)
This study is looking at a new medicine called MGC018 (also known as vobramitamab duocarmazine) for men with prostate cancer that has spread and is no longer responding to standard hormone therapy. Researchers want to see how well it works and if it's safe at two different dose levels.
For: Metastatic Castration-resistant Prostate CancerBelgium · Germany · France - Ongoing, recruitingPhase I and Phase II (Integrated)- Other
Phase 1/2 Dose Finding, Safety and Efficacy Study of Ibrutinib in Pediatric Subjects with Chronic Graft Versus Host Disease (cGVHD)
This study is looking at a medicine called ibrutinib for children and young people with chronic Graft Versus Host Disease (cGVHD). It aims to find the right dose and check how safe and effective it is for those aged 1 to 22 years.
For: Chronic Graft Versus Host Disease (cGVHD)France · Italy · Spain - Ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase 2b, Randomized, Double-masked, Multicenter, Dose-ranging, Sham-controlled Clinical Trial to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
This study is testing a new eye treatment called JNJ-81201887 for a condition called Geographic Atrophy (GA). GA is a serious eye problem linked to ageing that can cause blurry vision. Researchers want to see if this new treatment can slow down the worsening of GA.
For: Geographic AtrophyNetherlands · Belgium · Germany